Search
Vyne Therapeutics Inc
VYNEAdd to Watchlist
28.560USD
0.0000.00%
Close 07-27 16:00（ET）Quotes delayed by 15 min
18.71MMarket Cap
LossP/E TTM
Vyne Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-27The current valuation score of Vyne Therapeutics Inc is 8.12, ranking 165 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -56.98, which is -102.37% below the recent high of 1.35 and 0.00% above the recent low of -56.98.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.